Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
6,772 total articles
HUB Cyber Security Ltd., a Nasdaq-listed company specializing in confidential computing and AI-driven cybersecurity, announced the resignation of CEO Noah Hershcoviz effective immediately. The active Chairperson, Renah Persofsky, will temporarily increase her management role while the company searches for an interim CEO and plans to find a permanen…
Flexible Solutions International, Inc., a developer and manufacturer of biodegradable polymers and environmental technologies, announced a delay in releasing its full year 2025 financial results. The delay is attributed to late comments from the company's tax consultants, postponing the auditor's completion of the financial analysis. The company wi…
Axe Compute Inc. reported its full-year 2025 results, marking a foundational year in which it pivoted to focus on GPU compute infrastructure and digital asset treasury management. The company raised $343.5 million through PIPE transactions, transitioned leadership, renamed itself from Predictive Oncology Inc., and launched access to a distributed G…
Soulpower Acquisition Corporation (NYSE: SOUL) and SWB Holdings have amended their business combination agreement, adjusting the assets to be contributed and adding a significant new asset—the Uruguay Iron Mine—which consists of prospecting and exploration permits for high-grade iron projects in Uruguay. The combined company's pro-forma valuation i…
Edesa Biotech announced that their CEO, Dr. Par Nijhawan, will deliver the inaugural oral presentation at the ATS 2026 Respiratory Innovation Summit, showcasing Phase 3 clinical trial results of paridiprubart (EB05), an anti-TLR4 antibody for Acute Respiratory Distress Syndrome (ARDS). The data substantiates the potential clinical benefit of this n…
Nanobiotix announced its full year 2025 financial results and business update highlighting progress in its lead nanotherapeutic oncology programs, including JNJ-1900 (NBTXR3) across multiple solid tumors. The company strengthened its financial position through a $71 million non-dilutive royalty financing deal, extended its cash runway into early 20…
AgEagle Aerial Systems Inc., trading as EagleNXT on the NYSE, announced its fiscal 2025 results with increased drone sales, improved gross margins, a significant reduction in net loss, and enhanced capital structure. The company expanded its international defense footprint, advanced commercial market adoption, launched next-generation sensors, and …
FibroBiologics announced the successful manufacturing of its proprietary CYWC628 drug product under FDA CGMP standards, paving the way for first-in-human clinical trials targeting diabetic foot ulcers. This milestone represents a breakthrough as CYWC628 is the first fibroblast-based spheroid therapeutic candidate and its manufacturing the first lar…
NEXGEL, Inc. has rescheduled its Q4 and full-year 2025 financial results conference call to April 8, 2026, to provide shareholders with more detailed information about its proposed transaction with Celularity Inc. The company concurrently filed its 2025 Annual Report with the SEC. NEXGEL specializes in healthcare, beauty, and OTC hydrogel products …
Banzai International reported 169% full-year revenue growth in 2025, reaching $12.2 million, with improved gross margins and reduced net loss. The company expanded its AI-powered marketing and sales platform by acquiring ConnectAndSell assets, expected to more than double annual revenue and enhance sales acceleration capabilities. Continued focus o…
Trust Stamp reported a 2% revenue increase to $3.14 million in 2025, driven by an amended S&P 500 bank contract extending through 2031 with significant minimum revenue guarantees. Operating expenses decreased by 13% and comprehensive loss was reduced by nearly 32% year-over-year, reflecting improved operational efficiency. The company successfully …
Trust Stamp delivered robust business progress in Q1 2026, securing key contracts and expanding its footprint in telecommunications, workforce management, healthcare, and government sectors across Africa, Middle East, Japan, Europe, and the US. The company advanced its technology developments, made strategic acquisitions, and increased patents, pos…
CMB.TECH NV reported solid financial results for 2025, including a full-year profit of USD 139.1 million, supported by fleet rejuvenation with deliveries of 17 new vessels and sales of older ships generating substantial capital gains. The company completed a merger with Golden Ocean, expanded its presence on multiple stock exchanges including the N…
Spartacus Acquisition Corp. II announced that starting April 2, 2026, holders of their units can trade the Class A ordinary shares and warrants separately. The shares and warrants will trade under symbols TMTS and TMTSW, respectively, while the unsplit units will continue to trade as TMTSU on Nasdaq. The company is a blank check firm focused on bus…
Callan JMB Inc., a healthcare logistics and emergency preparedness company, reported its fiscal year 2025 financial results showing a revenue decrease from $6.6 million in 2024 to $5.7 million, driven primarily by reduced emergency preparedness demand. The company increased investment in growth initiatives including pharmaceutical logistics, U.S. o…
Our Bond, Inc., an AI-powered preventative personal security platform provider, filed its annual report highlighting significant progress since its Nasdaq listing in February 2026. The company has expanded its platform to 28 countries, secured contracts with major global corporations, and is capitalizing on growing enterprise adoption. Its innovati…
BioAtla, Inc., a clinical-stage biotech company focusing on conditionally active antibody therapeutics for solid tumors, reported Q4 and full year 2025 financial results. The company initiated a formal process to explore strategic options including asset sales and partnerships to maximize shareholder value, alongside a restructuring plan to reduce …
AVAX One Technology Ltd. announced its 2025 Q4 and full year financial results, showcasing significant revenue growth driven by its Avalanche digital asset treasury strategy and bitcoin mining operations. The company completed a $40 million share repurchase program and reported a large increase in cash reserves, aiming to scale its digital asset tr…
MDB Capital Holdings released its 2025 financial and operational results, highlighting its holdings in innovative technology companies such as eXoZymes and Paulex Bio, and progress on spin-offs like PatentVest and MDB Direct. The company reported stable operating expenses, a net cash use of $5.7 million for the year, and $22.3 million in net cash a…
OrthoPediatrics Corp., a pediatric orthopedic device company, announced that its President & CEO Dave Bailey and COO & CFO Fred Hite will participate in a fireside chat at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026. The event will be webcast live with replays available on the company's investor relations website.
SEALSQ Corp announced audited financial results for FY 2025 with revenue of $18.3 million, a 66% year-over-year increase driven by semiconductor and PKI products and the acquisition of IC'ALPS. The company expects Q1 2026 revenue to exceed $4 million and reaffirms full-year 2026 guidance projecting 50%-100% revenue growth. SEALSQ is accelerating Po…
Lesaka Technologies, a South African fintech company listed on NASDAQ and JSE, will release its Q3 2026 financial results on May 6, 2026, followed by an investor webcast and conference call on May 7. The company offers integrated financial services targeting underserved Southern African consumers and merchants.
Rail Vision Ltd. announced strong financial results for 2025, with revenue increasing 14.4% to $1.487 million and maintaining a robust balance sheet with approximately $20 million in cash and zero debt. The company advanced installations with Israel Railways, expanded into Latin America and Central America, and entered the Indian market through a p…
LIXTE Biotechnology filed its 2025 Annual Report highlighting leadership changes, expanded clinical trials for its lead cancer drug LB-100, successful capital raises, and the acquisition of Liora Technologies to enhance cancer treatment technologies. These developments position the company for growth in cancer therapeutics and med-tech innovation.
Jupiter Neurosciences, a clinical-stage pharmaceutical firm focused on neuroinflammation and healthy aging, will present its progress on its JOTROL™ platform and product line at the Emerging Growth Conference on April 2, 2026. The company is advancing a therapeutic pipeline targeting CNS disorders including Parkinson's and Alzheimer's, alongside ex…
